0

544694

ANL

img img img img
No Data Available

Accretion Nutraveda Limited Share Price Update

As of the latest trading session, Accretion Nutraveda Limited is trading at ₹269, up by ₹15.50 or 6.11% from its previous close. The stock has moved between ₹245.00 and ₹269.00 today. Over the past year, the stock has delivered a return of 0.00%. In the last month, it has returned 28.03%.

Investment Returns

Over 1 Month 28.03% Over 3 Months 36.29% Over 6 Months 32.58% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Accretion Nutraveda Limited fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 186.80
  • P/E Ratio (TTM) 0.00
  • Beta -0.19
  • Book Value / share 42.40
  • Return on equity 81.18%
  • EPS (TTM) 0.00
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.00
info icon alternate text

Accretion Nutraveda Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2025 (Values in Cr)
Revenue 16.00
Operating Expense 12.87
Net Profit 2.61
Net Profit Margin (%) 16.31
Earnings Per Share (EPS) 71.91
EBITDA 3.77
Effective Tax Rate (%) 17.92
Particulars MAR 2024 (Values in Cr)
Revenue 5.01
Operating Expense 4.28
Net Profit 0.82
Net Profit Margin (%) 16.36
Earnings Per Share (EPS) 22.83
EBITDA 1.41
Effective Tax Rate (%) 9.89
Particulars MAR 2023 (Values in Cr)
Revenue 2.90
Operating Expense 2.78
Net Profit 0.28
Net Profit Margin (%) 9.65
Earnings Per Share (EPS) 7.79
EBITDA 0.79
Effective Tax Rate (%) 3.44
Particulars MAR 2025 (Values in Cr)
Book Value / Share 109.83
ROE % 81.18
ROCE % 56.66
Total Debt to Total Equity 0.94
EBITDA Margin 23.56
Particulars MAR 2024 (Values in Cr)
Book Value / Share 30.14
ROE % 113.89
ROCE % 41.22
Total Debt to Total Equity 3.09
EBITDA Margin 28.34
Particulars MAR 2023 (Values in Cr)
Book Value / Share 7.31
ROE % 77.78
ROCE % 20.60
Total Debt to Total Equity 7.58
EBITDA Margin 27.24
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 10.86
Total Liabilities 10.86
Total Equity 5.34
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 24.05
Return on Capital (%) 28.38
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 4.63
Total Liabilities 4.63
Total Equity 1.08
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 17.71
Return on Capital (%) 25.22
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 4.06
Total Liabilities 4.06
Total Equity 0.26
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 6.91
Return on Capital (%) 12.55
Particulars MAR 2025 (Values in Cr)
Net Income 3.18
Cash from Operations -1.66
Cash from Investing -0.87
Cash from Financing 2.98
Net change in Cash -0.10
Free Cash Flow -0.79
Particulars MAR 2024 (Values in Cr)
Net Income 0.91
Cash from Operations 0.33
Cash from Investing -0.15
Cash from Financing -0.03
Net change in Cash 0.03
Free Cash Flow 0.48
Particulars MAR 2023 (Values in Cr)
Net Income 0.28
Cash from Operations 0.68
Cash from Investing 0.00
Cash from Financing -0.63
Net change in Cash 0.04
Free Cash Flow 0.68
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.33 13.56 1.62 240.09 23.12 40.44
BLISS GVS PHARMA LTD. 269.70 25.78 2.51 2853.13 105.05 280.20
CIPLA LTD. 1333.55 22.66 3.27 107721.85 1165.55 1672.20
FERMENTA BIOTECH LIMITED 298.60 9.93 2.24 878.81 252.15 399.00
GLAXOSMITHKLINE PHARMA LT 2362.25 39.79 23.43 40017.94 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.33 30.13 4.36 240.09 23.12 40.44
AMRUTAJAN HEALTH LTD 533.50 26.68 4.50 1542.38 490.00 789.95
ASTRAZENECA PHARMA IND LT 8233.50 98.95 25.76 20583.75 7630.00 10653.05
BLISS GVS PHARMA LTD. 269.70 36.74 2.58 2853.13 105.05 280.20

Accretion Nutraveda Limited shareholding pattern

Holding
13.97%
73.48%
6.03%
6.5%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

Accretion Nutraveda Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
258.00 1.77 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 250.00
  • 26 Days 215.90
  • 10 Days 236.70
  • 50 Days 197.40
  • 12 Days 232.70
  • 100 Days 197.40
  • 20 Days 221.50
  • 200 Days 197.40
253.82 PIVOT
First Support 241.93 First Resistance 265.38 Second Support 230.37 Second Resistance 277.27 Third Support 218.48 Third Resistance 288.83
RSI 68.90 ADX 35.03 MACD 16.75 Williams % R -37.93 Commodity Channel Index (CCI) 140.86
Date 2026-05-05 Week 36250.00 Same Day 30000.00 Month 16063.00
1 Year -0.20 3 Year -0.22
Over 1 Month
28.03% down
Over 1 Year
0.00% down
Over 3 Months
36.29% down
Over 3 Years
0.00% down
Over 6 Months
32.58% down
Over 5 Years
0.00% down

Accretion Nutraveda Limited Corporate Actions

Top Gainers

Top Losers

Accretion Nutraveda Limited Share Price

Accretion Nutraveda Limited was initially incorporated as a Private Limited Company on March 16, 2021 and has subsequently, converted the status into a Public Limited Company vide Certificate of Incorporation issued by the Registrar of Companies, Central Processing Centre w.e.f. May 2, 2025.

The Company, established at Ahmedabad, is a healthcare-focused Contract Development and Manufacturing Organization (CDMO), offering specialized services to a diverse range of clients across the various industries. It specialize in ayurvedic and nutraceutical products including Tablets, Capsules, Oral Liquids, Oral Powders, External Preparation and Oils. Apart from these, it offer a diverse range of dosage forms, leveraging both Classical Ayurvedic principles and modern nutraceutical science.

The products include Tablets, such as film-coated and chewable varieties, for applications in liver care, gynecological care, bone and joint health, and respiratory support. Company manufacture Capsules, including hard gelatin and HPMC capsules, targeting areas like liver detoxification, women's health, and cognitive support. The oral liquids include syrups, suspensions, and tonics, which are particularly suited for paediatric and geriatric segments.

Additionally, Company produces Traditional Ayurvedic Powders known as churans for digestive health, medicated ayurvedic oils for
musculoskeletal and dermatological applications using traditional processes, and a range of external preparations like balms, ointments, creams, and gels for pain relief, skin care, and hair care.

Company is planning to issue 19,20,000 equity shares of face value of Rs 10 each via its initial public offering.

Parent organization Indian Private
NSE symbol [-]
Founded 2021
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Accretion Nutraveda Ltd?

Answer Field

Accretion Nutraveda Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 258.00 as on May 06 2026 03:25 PM.

What is the Market Cap of Accretion Nutraveda Ltd Share?

Answer Field

The market cap of Accretion Nutraveda Ltd for NSE ₹ 0.00 & for BSE ₹ 186.80 as on May 06 2026 03:25 PM.

What is the 52 Week High and Low of Accretion Nutraveda Ltd?

Answer Field

The 52 Week High and Low of Accretion Nutraveda Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 288.00 and ₹ 150.10.

What is 1 year return for Accretion Nutraveda Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Accretion Nutraveda Ltd Share?

Answer Field

As on May 06 2026 03:25 PM the price-to-earnings (PE) ratio for Accretion Nutraveda Ltd share is 0.00.

What is the PB ratio of Accretion Nutraveda Ltd Share?

Answer Field

As on May 06 2026 03:25 PM, the price-to-book (PB) ratio for Accretion Nutraveda Ltd share is 42.40.

How to Buy Accretion Nutraveda Ltd Share?

Answer Field

You can trade in Accretion Nutraveda Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Accretion Nutraveda Ltd Share on Bajaj Broking App?

Answer Field

To buy Accretion Nutraveda Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Accretion Nutraveda Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|